![Robert H. Uhl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert H. Uhl
Corporate Officer/Principal bei
Westwicke Partners LLC
Profil
Robert H.
Uhl is currently the Managing Director at Westwicke Partners LLC, a position held since 2011.
Formerly, Mr. Uhl was Director-Investor Relations at Halozyme Therapeutics, Inc. in 2010 and served as Investor Relations Contact at DMK Pharmaceuticals Corp.
Aktive Positionen von Robert H. Uhl
| Unternehmen | Position | Beginn |
|---|---|---|
Westwicke Partners LLC
 Westwicke Partners LLC Investment ManagersFinance Provides investment advisory and management consulting services | Corporate Officer/Principal | 01.01.2011 |
Ehemalige bekannte Positionen von Robert H. Uhl
| Unternehmen | Position | Ende |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Investor Relations Kontakt | - |
| HALOZYME THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
DMK Pharmaceuticals Corp.
 DMK Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of opioid overdose and substance-use disorders | Health Technology |
Westwicke Partners LLC
Westwicke Partners LLC Investment ManagersFinance Provides investment advisory and management consulting services | Finance |
